ROKIT Healthcare Inc. (KOSDAQ:376900)
52,300
-2,400 (-4.39%)
At close: Feb 6, 2026
ROKIT Healthcare Revenue
ROKIT Healthcare had revenue of 6.95B KRW in the quarter ending September 30, 2025, with 173.70% growth. This brings the company's revenue in the last twelve months to 20.33B, up 54.62% year-over-year. In the year 2024, ROKIT Healthcare had annual revenue of 13.11B with 5.59% growth.
Revenue (ttm)
20.33B
Revenue Growth
+54.62%
P/S Ratio
40.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
816.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.11B | 693.67M | 5.59% |
| Dec 31, 2023 | 12.42B | 3.27B | 35.70% |
| Dec 31, 2022 | 9.15B | 2.41B | 35.76% |
| Dec 31, 2021 | 6.74B | 2.75B | 68.94% |
| Dec 31, 2020 | 3.99B | -6.20B | -60.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 89.78B |
| S.Biomedics | 16.96B |
| JS Link | 16.14B |
| AprilBio | 8.97B |
| Qurient | 8.28B |
| AbClon | 3.80B |
| IntoCell | 1.68B |
| ToolGen | 1.07B |